Can Ultrasound Be as a Surrogate Marker for Diagnosing a Papillary Thyroid Cancer? Comparison with BRAF Mutation Analysis.
10.3349/ymj.2014.55.4.871
- Author:
Jae Young SEO
1
;
Eun Kyung KIM
;
Jung Hwan BAEK
;
Jung Hee SHIN
;
Kyung Hwa HAN
;
Jin Young KWAK
Author Information
1. Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea. docjin@yuhs.ac
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Thyroid cancer;
BRAF mutation;
thyroid ultrasound
- MeSH:
Adult;
Aged;
Biological Markers;
Biopsy, Fine-Needle;
Carcinoma/*diagnosis/genetics/*ultrasonography;
Cytodiagnosis;
Female;
Humans;
Male;
Middle Aged;
Proto-Oncogene Proteins B-raf/*genetics;
Retrospective Studies;
Thyroid Gland/metabolism/pathology;
Thyroid Neoplasms/*diagnosis/genetics/*ultrasonography;
Thyroid Nodule/metabolism/pathology;
Young Adult
- From:Yonsei Medical Journal
2014;55(4):871-878
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: We investigated the merit of ultrasound (US) features and BRAF(V600E) mutation as an additional study of cytology and compared the diagnostic performances of cytology alone, cytology with US correlation, cytology with BRAF(V600E) mutation, and a combination of cytology, US, and BRAF(V600E) mutation all together. MATERIALS AND METHODS: This study included 185 patients (mean age, 48.4 years; range 20-77 years) with 191 thyroid nodules who underwent US-guided fine-needle aspiration (FNA) with an additional BRAF(V600E) mutation test. Three radiologists highly experienced in thyroid imaging retrospectively reviewed US images and classified each nodule into two categories (positive for malignancy or negative for malignancy). Interobserver variability (IOV) of US assessment between the three readers was estimated using the generalized kappa statistic of Landis and Koch. We also calculated the diagnostic performances of these studies. RESULTS: There were 131 cases of malignancy (131/191, 68.6%) and 60 cases of benign nodules (60/191, 31.4%). In terms of IOV of US assessment, the generalized kappa value was 0.242, indicating fair agreement was reached. The combination of cytology with BRAF(V600E) showed higher specificity (100%) and positive predictive value (PPV) (100%) compared to the combination of cytology, BRAF(V600E), and US (specificity 28.3%, 66.7%, 68.3%; PPV 74.6%, 86.6%, 86.8%, respectively; p<0.001). However, cytology with BRAF(V600E) showed lower sensitivity (84.7%) than cytology with BRAF(V600E) and US (96.2%, 98.5%, 95.4%, respectively; p<0.001). CONCLUSION: Considering the diagnostic performance and low reproducibility of US, the combination of FNA with BRAF(V600E) is the most reliable and objective method for diagnosing thyroid malignancy.
